Trending Topic

Acute myeloid leukaemia
3 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

“We are facing an exciting era of fast-paced drug development in acute myeloid leukaemia” writes Gianfranco Bittar and colleagues at Baylor College of Medicine, Houston, TX, USA, in a review published in touchREVIEWS in Oncology & Haematology. In 2020, there were an estimated 21,450 new patients with acute myeloid leukaemia (AML) and 11,180 AML-related deaths […]

touchLearning Activities

Speciality Filter

Select Specialty or Clinical Area

Clear All
Update Filters
Close Popup
Mark CompleteCompleted
BookmarkBookmarked

Dr Côme Bommier reflects on the influences that shaped his career, the evolving landscape of lymphoma treatment and the central role of patients in clinical decision-making. With a clear vision for more personalised and lasting care, he offers thoughtful insight into the challenges and responsibilities of modern haematology.

Mark CompleteCompleted
BookmarkBookmarked

Dr. David Porter, President of ASTCT, outlines his vision for the Society’s future, emphasizing expanded access to cell therapies, multidisciplinary collaboration, and a bold strategic plan through 2030. He highlights exciting advances in treating autoimmune diseases and solid tumors, positioning ASTCT to lead in a rapidly evolving therapeutic landscape.

touchVisionary Voices
Mark CompleteCompleted
BookmarkBookmarked

In this episode, we explore the future of continuing medical education (CME) with the team behind touchIME. Hannah Fisher and Matthew Goodwin share insights into global and US trends, the importance of patient inclusivity and how educational outcomes are evolving to better measure the direct impact of learning on clinical practice and patient care.

Mark CompleteCompleted
BookmarkBookmarked

Dr Zachary Frosch, Fox Chase Cancer Center, shares how patient priorities guide his clinical decisions and how his research stems from real-world challenges. He also reflects on key lessons from mentorship and the ongoing dialogue between the clinic and the research lab that shapes his work.

Mark CompleteCompleted
BookmarkBookmarked

The 30th EHA Congress will take place in Milan from 12–15th June 2025 and touchHAEMATOLOGY are thrilled to be attending on site, speaking with leading experts across the field. Keep an eye out on our website and social media for the latest news, updates and Q&As fresh from Milan!

Mark CompleteCompleted
BookmarkBookmarked

Dr. Esra Gülderen discusses her path into hematology, the critical role of mentorship, and how early research experiences shaped her confidence. Now a Co-chair of the EBMT Trainee Committee, she shares what motivates her and why clear communication, curiosity, and resilience are essential traits for aspiring haematologists.

Mark CompleteCompleted
BookmarkBookmarked

In this interview, Dr Elena Crisà (Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy) shares her insights into the most fulfilling aspects of practicing haematology, from working in cutting-edge new treatment options in clinical trials to guiding patients through complex treatment decisions.

Mark CompleteCompleted
BookmarkBookmarked

Protagonist Therapeutics Inc. and Takeda have shared positive topline findings from the phase III VERIFY trial (NCT05210790), which investigated rusfertide in patients with polycythemia vera (PV) who require frequent phlebotomies. Participants were randomly assigned to receive either rusfertide or a ...

Mark CompleteCompleted
BookmarkBookmarked

"Our job is to empower patients with data to make the most informed decision, together" For Dr. Carmelo Gurnari (Cleveland Clinic, Cleveland, OH, USA; University of Tor Vergata, Rome, Italy), haematological oncology is more than a profession – it is a ...

Mark CompleteCompleted
BookmarkBookmarked

Nurses account for the largest group of professionals in the healthcare system and there are an estimated 29 million nurses worldwide (WHO, 2024). Nursing practice needs to be dynamic in order to respond to the changing needs of an aging population and ...

Mark CompleteCompleted
BookmarkBookmarked

CD7-targeted CAR T-cell therapy, WU-CART-007, demonstrates encouraging anti-leukemic activity and a manageable safety profile in heavily pretreated patients with relapsed/refractory (R/R) T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma (T-ALL/LBL). This updated analysis from the phase II portion ...

Mark CompleteCompleted
BookmarkBookmarked

A chemotherapy-free approach combining ibrutinib-rituximab (IR) has outperformed standard chemotherapy regimens in treating older patients with newly-diagnosed mantle cell lymphoma (MCL), according to findings from the ENRICH trial presented at the 66th American Society of Hematology Annual Meeting. The study ...

Mark CompleteCompleted
BookmarkBookmarked

The American Society of Hematology (ASH) held its 66th Annual Meeting from 7–10 December 2024. Among the highlights of the meeting were six late-breaking abstracts that have the potential to influence how healthcare professionals approach a range of condition,s from introducing ...

Mark CompleteCompleted
BookmarkBookmarked

With the the 66th ASH Annual Meeting & Exposition still fresh in our minds, Dr Rahul Banerjee (Fred Hutch Cancer Center, Seattle, WA, USA) and Dr Samer Al Hadidi (University of Arkansas for Medical Sciences, Little Rock, AR, USA) outline ...

Mark CompleteCompleted
BookmarkBookmarked

The IMpactMF trial is a phase 1/1b study evaluating the addition of Imetelstat to ruxolitinib for myelofibrosis patients who show an inadequate response to ruxolitinib alone. By combining these therapies earlier in treatment, the study aims to assess safety, tolerability ...

Mark CompleteCompleted
BookmarkBookmarked

As 2024 draws to a close, we’re celebrating a great year of content. From insightful expert Q&As and news articles to conference highlights and a wealth of medical education, it’s been a year filled with content that we hope has been useful to our audience. We’ve had the privilege of connecting with leading experts and working alongside medical societies to support the haematology community with high-quality, easily accessible content.

Mark CompleteCompleted
BookmarkBookmarked

The 66th ASH Annual Meeting and Exposition 2024 in San Diego saw approximately 30,000 visitors, 8,000 abstracts and 275 exhibitors. With so much exciting new data and scientific breakthroughs presented, touchHAEMATOLOGY is excited to break this down and bring you some of the highlights. ...

Mark CompleteCompleted
BookmarkBookmarked

 This interview features Dr Nico Gagelmann (University Medical Center Hamburg-Eppendorf, Hamburg, Germany) and Dr Claire Horgan (Royal Manchester Children's Hospital, Manchester, UK) co-chairs of the European Society for Blood and Marrow Transplantation (EBMT) Trainee Committee. Together, they discuss their motivations ...

Load More...
touchHAEMATOLOGY touchHAEMATOLOGY

Register Now!

Explore the latest in medical education and stay current in your field. Create a free account to track your learning.

  • Save your progress for video
  • Keep track of your CME credits
  • Add personalised learning notes
  • Receive updates from course leaders and faculty
  • Be the first to hear about new and exciting interactive learning opportunities
Close Popup